Weekly Quick Hits (Research Triangle Park) – Week of May 15, 2023 By Alex KeownMay 19, 2023 Funding, Awards and Collaborations Science 37 Wins MedTech Breakthrough Award for “Best Overall [….]
Investment Groups Acquire Syneos Health for $7.1 Billion By Alex KeownMay 11, 2023 Shares of Syneos Health jumped more than 19% on May 10 after a consortium of investors announced [….]
Weekly Quick Hits (Research Triangle Park) – Week of April 3, 2023 By Alex Keown, Mark Terry, and Sarah EllinwoodApril 7, 2023 Funding, Awards and Collaborations Sciencix Named SBA Exporter [….]
Weekly Quick Hits (Research Triangle Park) – Week of March 20, 2023 By Alex Keown, Mark Terry, and Sarah EllinwoodMarch 24, 2023 Funding, Awards and Collaborations Syneos Health and Microsoft [….]
Biopharmaceutical solutions company Syneos Health has forged a strategic, data-driven predictive analytics partnership with New York-based KX, the maker of analytics engine kdb, to create a new class of data and AI management engine.
Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced an expanded partnership with Datavant, the leader in helping organizations securely connect health data. The increasing collaboration between the companies will further leverage the full suite of capabilities in Datavant Switchboard and Datavant’s large data ecosystem to accelerate the clinical development and commercialization of new therapies for patients.
Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 2021 Sustainability Report. The Report spotlights how the Company and its more than 29,000 employees have acted on their shared purpose to lead with a product development mindset and expand the Company’s Environmental, Social and Governance (ESG) impact. The Company continues to advance external and internal initiatives associated with achieving its Vision – Shortening the Distance from Lab to Life®.
